Citigroup
ANIP icon

Citigroup’s ANI Pharmaceuticals ANIP Stock Holding History

Citigroup’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-500
Closed -$14K – 7345
2020
Q3 		$14K Sell
500
-200
-29% -$5.96K ﹤0.01% 6395
2020
Q2 		$23K Hold
700
– – ﹤0.01% 6502
2020
Q1 		$29K Sell
700
-700
-50% -$37.2K ﹤0.01% 6426
2019
Q4 		$86K Sell
1,400
-500
-26% -$33.1K ﹤0.01% 5883
2019
Q3 		$138K Sell
1,900
-400
-17% -$29.9K ﹤0.01% 5446
2019
Q2 		$189K Buy
2,300
+1,700
+283% +$121K ﹤0.01% 5317
2019
Q1 		$42K Sell
600
-1,900
-76% -$112K ﹤0.01% 6463
2018
Q4 		$113K Sell
2,500
-100
-4% -$5.24K ﹤0.01% 5542
2018
Q3 		$147K Buy
2,600
+400
+18% +$24.5K ﹤0.01% 5535
2018
Q2 		$147K Sell
2,200
-8,900
-80% -$556K ﹤0.01% 5354
2018
Q1 		$646K Buy
11,100
+5,000
+82% +$317K ﹤0.01% 3720
2017
Q4 		$393K Buy
6,100
+3,000
+97% +$187K ﹤0.01% 4350
2017
Q3 		$163K Buy
+3,100
New +$148K ﹤0.01% 5153
2017
Q2 		– Sell
-3,800
Closed -$188K – 7329
2017
Q1 		$188K Sell
3,800
-7,000
-65% -$393K ﹤0.01% 4707
2016
Q4 		$655K Buy
10,800
+9,800
+980% +$599K ﹤0.01% 4102
2016
Q3 		$66K Buy
+1,000
New +$62.5K ﹤0.01% 5474

Other funds holding ANIP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Citigroup's ANIP Position: Q1 2026 in Review

Citigroup reduced its ANI Pharmaceuticals (ANIP) stake by 16% in Q1 2026, selling an estimated $2.16M and leaving 144,281 shares worth $11.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1407.

Citigroup first reported a position in ANIP in Q2 2013 and has held it in 49 quarters since. The position peaked at $13.6M in Q4 2025. 280 funds tracked by Wall St. Rank hold ANIP as of Q1 2026.

  • Citigroup held 144,281 shares of ANI Pharmaceuticals worth $11.1M as of Q1 2026.
  • Citigroup sold 27,690 ANI Pharmaceuticals shares in Q1 2026, an estimated $2.16M.
  • ANI Pharmaceuticals made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #1407 holding.
  • Citigroup first reported a position in ANI Pharmaceuticals in Q2 2013 and has held it in 49 quarters since.
  • Citigroup's ANI Pharmaceuticals position peaked at $13.6M in Q4 2025.
  • 280 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.